SEMABIZ, Inc. | ChosaReport.com

日本と海外の市場調査レポート＆サービスを取り扱っております。

世界のマイクロサージェリーおよびスーパーマイクロサージェリー市場 : 2032年までの予測

Global Microsurgery & Super-Microsurgery Market

Global Microsurgery & Super-Microsurgery Market by Equipment (Operating Microscopes, Super Micro Sutures, Micro Forceps, Microsurgery Needle Holder, Surgical Scalpel/ Ophthalmic Knives, Others), by Procedure (Orthopedic Microsurgery, Ophthalmic Microsurgery, Plastic & Reconstructive Microsurgery, ENT Microsurgery, Neurological Microsurgery, Gynecological & Urological Microsurgery, Others), by End User (Hospitals, Ambulatory Surgical Centers, Others), by Region (North America, Europe, Asia Pacific, Rest of the World) Forecast till 2032

商品番号 : SMB-81615

出版社Market Research Future
出版年月2025年7月
ページ数148
価格タイプシングルユーザライセンス
価格USD 4,950
種別英文調査報告書

世界のマイクロサージェリーおよびスーパーマイクロサージェリー市場 : 機器（手術用顕微鏡、超微細縫合糸、マイクロ鉗子、マイクロサージェリー用針ホルダー、外科用メス/眼科用メス、その他）、処置別（整形外科用マイクロサージェリー、眼科用マイクロサージェリー、形成外科・再建外科用マイクロサージェリー、耳鼻咽喉科用マイクロサージェリー、神経科用マイクロサージェリー、婦人科・泌尿器科用マイクロサージェリー、その他）、エンドユーザー別（病院、外来手術センター、その他）、地域別（北米、ヨーロッパ、アジア太平洋、その他の国）2032年までの予測

Market Overview

Global microsurgery and super-microsurgery market was estimated to be worth USD 1,961.54 million in 2022 and is projected to grow at a Compound Annual Growth Rate (CAGR) of 6.07% from 2023 to 2032, reaching USD 3,783.66 million in 2032.

世界のマイクロサージェリーおよびスーパーマイクロサージェリー市場は、2022年に19億6,154万米ドルに達すると推定され、2023年から2032年にかけて6.07%の複合年間成長率（CAGR）で成長し、2032年には37億8,366万米ドルに達すると予測されています。

Global microsurgery and super-microsurgery market is driven by the increasing volume of surgical procedures and the rising geriatric population. Advancements in R&D, growing transplant surgeries, and the need for precision in orthopedic and reconstructive procedures contribute significantly. Aging-related conditions and chronic diseases further boost demand for microsurgical interventions with high success rates across medical disciplines.

世界的なマイクロサージェリーおよびスーパーマイクロサージェリー市場は、外科手術件数の増加と高齢化人口の増加によって牽引されています。研究開発の進歩、移植手術の増加、そして整形外科および再建手術における精密さへのニーズが、この市場の成長に大きく貢献しています。加齢に伴う疾患や慢性疾患も、医療分野全体において高い成功率を誇るマイクロサージェリー介入の需要をさらに高めています。

Global microsurgery and super-microsurgery market faces restraints due to risks like infection, poor healing, nerve damage, scarring, anesthesia complications, and potential need for revision surgeries.

Global microsurgery and super-microsurgery market is poised for growth due to the rising prevalence of lifestyle disorders and ongoing technological advancements. Increasing product approvals, government support, and innovation, such as developments in ophthalmic surgical microscopes, are enhancing procedural precision. As chronic diseases rise among both aging and younger populations, the demand for advanced microsurgical solutions is expected to surge.

Market Segmentations

Global microsurgery and super-microsurgery market is categorized based on equipment type and surgical procedures. The equipment segment comprises operating microscopes, super micro sutures, micro forceps, microsurgery needle holders, surgical scalpels or ophthalmic knives, and other related tools.

Orthopedic Microsurgery, Plastic & Reconstructive Microsurgery, ENT Microsurgery, Neurological Microsurgery, Ophthalmic Microsurgery, Gynecological & Urological Microsurgery are the part of procedure types of global market.

In terms of end user, global microsurgery and super microsurgery market is categorized into hospitals and ambulatory surgical centers and others.

Based on the regional category, global microsurgery and super microsurgery market has been segmented into North America, Europe, Asia Pacific, and rest of the world.

Regional Insights

Global microsurgery and super-microsurgery market has seen notable regional developments, each shaped by unique drivers and challenges. In North America, market growth has been robust, driven by continuous technological advancements and an increasing preference for minimally invasive procedures across several specialties.

In Europe, the market has evolved significantly, fueled by innovations in medical technology, a growing elderly population, and the rising prevalence of chronic conditions. Both microsurgeries, using fine instruments and microscopes, and the more advanced super-microsurgery have become integral in fields such as plastic surgery, ophthalmology, orthopedics, and reconstructive surgery.

The Asia Pacific region is witnessing rapid progress due to its strong focus on research and development. Leading academic and medical institutions are pioneering new techniques, enhancing the precision and scope of these delicate surgical procedures.

Meanwhile, in the Middle East, Africa, and Latin America, the market is expanding but faces notable challenges. Although there is growing interest, limited access to specialized training, high equipment costs, and uneven healthcare infrastructure restrict the broader adoption of microsurgery and super-microsurgery across these regions.

Major Players

Johnson & Johnson Services Inc, Carl Zeiss Meditec, KLS Martin Group, Topcon Corporation, Olympus Corporation, Kontron AG, B. Braun SE, Zimmer Biomet, Global Surgical Corporation, Karl Kaps GmbH & Co. KG, Smith+Nephew, Stille AB, Medtronic, Stryker, BVI, Microsurgery Instruments Inc, Haag-Streit Group, Peter Lazic GmbH, Alco Inc, Synovis Micro Companies Alliance Inc. are the key companies of global microsurgery and super microsurgery market.

TABLE OF CONTENTS

1 EXECUTIVE SUMMARY …………….. 22

2 MARKET INTRODUCTION ………….. 24

2.1 DEFINITION ………………………………………………………….. 24

2.2 SCOPE OF THE STUDY ………………………………………… 24

2.3 RESEARCH OBJECTIVE ………………………………………. 24

2.4 MARKET STRUCTURE ………………………………………… 24

3 RESEARCH METHODOLOGY …….. 25

3.1 OVERVIEW ……………………………………………………………. 25

3.2 DATA FLOW ………………………………………………………….. 27

3.2.1 DATA MINING PROCESS ………………………………….. 27

3.3 PURCHASED DATABASE: ……………………………………. 28

3.4 SECONDARY SOURCES: ………………………………………. 29

3.4.1 SECONDARY RESEARCH DATA FLOW: …………………….. 30

3.5 PRIMARY RESEARCH: …………………………………………. 31

3.5.1 PRIMARY RESEARCH DATA FLOW: ……………………. 32

3.5.2 PRIMARY RESEARCH: NUMBER OF INTERVIEWS CONDUCTED ……………………………………………………………………………. 33

3.5.3 PRIMARY RESEARCH: REGIONAL COVERAGE …………… 33

3.6 APPROACHES FOR MARKET SIZE ESTIMATION: ………………………………………………………………………………. 34

3.6.1 REVENUE ANALYSIS APPROACH ………………………… 34

3.7 DATA FORECASTING…………………………………………… 34

3.7.1 DATA FORECASTING TECHNIQUE ………………………… 35

3.8 DATA END USERLING …………………………………………. 36

3.8.1 MICROECONOMIC FACTOR ANALYSIS: ……………………. 36

3.8.2 DATA END USERLING: …………………………………….. 37

3.9 TEAMS AND ANALYST CONTRIBUTION …………. 38

4 MARKET DYNAMICS …………………. 40

4.1 INTRODUCTION ……………………………………………………. 40

4.2 DRIVERS ………………………………………………………………… 41

4.2.1 GROWING NUMBER OF SURGICAL PROCEDURES …………. 41

4.2.2 INCREASING NUMBER OF GERIATRIC POPULATION ………. 41

4.3 RESTRAINTS ………………………………………………………… 42

4.3.1 COMPLICATIONS AND RISKS DUE TO THE PROCEDURE …. 42

4.4 OPPORTUNITY ……………………………………………………… 43

4.4.1 INCREASING INCIDENCE OF LIFESTYLE DISORDERS AND GROWING TECHNOLOGICAL ADVANCEMENTS …………………………………. 43

5 MARKET FACTOR ANALYSIS …….. 45

5.1 VALUE CHAIN ANALYSIS ………………………………….. 45

5.1.1 R&D ……………………………………………………….. 46

5.1.2 MANUFACTURING ………………………………………….. 46

5.1.3 DISTRIBUTION AND SALES ……………………………….. 47

5.1.4 POST-SALES MONITORING ………………………………… 47

5.2 PORTER’S FIVE FORCES MODEL ……………………….. 48

5.2.1 THREAT OF NEW ENTRANTS ………………………………. 49

5.2.2 BARGAINING POWER OF SUPPLIERS ……………………… 49

5.2.3 THREAT OF SUBSTITUTES …………………………………. 49

5.2.4 BARGAINING POWER OF BUYERS ………………………… 49

5.2.5 INTENSITY OF RIVALRY …………………………………….. 49

5.3 IMPACT OF COVID-19 ON THE GLOBAL MICROSURGERY & SUPER-MICROSURGERY MARKET … 50

5.3.1 IMPACT ON SUPPLY CHAIN ………………………………. 50

5.3.2 IMPACT ON KEY PLAYERS ………………………….. 50

5.3.3 IMPACT ON DEMAND AND SUPPLY ………………. 51

6 GLOBAL MICROSURGERY & SUPER-MICROSURGERY MARKET,  BY EQUIPMENT ………….. 52

6.1 OVERVIEW ……………………………………………………………. 52

6.2 OPERATING MICROSCOPES ……………………………….. 55

6.3 SUPER MICRO SUTURES …………………………………….. 55

6.4 MICRO FORCEPS ………………………………………………….. 56

6.5 MICROSURGERY NEEDLE HOLDER …………………… 56

6.6 SURGICAL SCALPEL/ OPHTHALMIC KNIVES ….. 57

6.7 OTHERS …………………………………………………………………. 57

7 GLOBAL MICROSURGERY & SUPER-MICROSURGERY MARKET,  BY PROCEDURE ………… 58

7.1 OVERVIEW ……………………………………………………………. 58

7.2 ORTHOPEDIC MICROSURGERY ………………………….. 61

7.3 OPHTHALMIC MICROSURGERY ………………………… 62

7.4 PLASTIC & RECONSTRUCTIVE MICROSURGERY ……………………………………………………………………………….. 62

7.5 ENT MICROSURGERY ………………………………………….. 63

7.6 NEUROLOGICAL MICROSURGERY …………………….. 63

7.7 GYNECOLOGICAL & UROLOGICAL MICROSURGERY …………………………………………………………………………… 64

7.8 OTHERS …………………………………………………………………. 64

8 GLOBAL MICROSURGERY & SUPER-MICROSURGERY MARKET,  BY END USER …………….. 65

8.1 OVERVIEW ……………………………………………………………. 65

8.2 HOSPITALS …………………………………………………………… 67

8.3 AMBULATORY SURGICAL CENTERS ………………… 68

8.4 OTHERS …………………………………………………………………. 68

9 GLOBAL MICROSURGERY & SUPER-MICROSURGERY MARKET, BY REGION …………………. 69

9.1 OVERVIEW ……………………………………………………………. 69

9.2 NORTH AMERICA ………………………………………………… 71

9.2.1 US………………………………………………………….. 75

9.2.2 CANADA …………………………………………………. 76

9.3 EUROPE …………………………………………………………………. 78

9.3.1 GERMANY …………………………………………………. 82

9.3.2 FRANCE ……………………………………………………. 83

9.3.3 UK …………………………………………………………. 85

9.3.4 ITALY ……………………………………………………….. 86

9.3.5 SPAIN ……………………………………………………… 88

9.3.6 REST OF EUROPE ………………………………………….. 89

9.4 ASIA-PACIFIC ……………………………………………………….. 91

9.4.1 CHINA …………………………………………………….. 95

9.4.2 JAPAN ……………………………………………………. 96

9.4.3 INDIA ……………………………………………………… 98

9.4.4 AUSTRALIA ……………………………………………… 99

9.4.5 SOUTH KOREA ………………………………………….. 101

9.4.6 REST OF ASIA-PACIFIC ………………………………. 102

9.5 REST OF WORLD ………………………………………………….. 104

9.5.1 MIDDLE EAST …………………………………………… 108

9.5.2 SOUTH AMERICA ………………………………………. 109

10 COMPETITIVE LANDSCAPE ………. 111

10.1 INTRODUCTION ……………………………………………………. 111

10.2 MARKET SHARE ANALYSIS, 2022 ……………………. 111

10.3 COMPETITOR DASHBOARD………………………………… 112

10.4 PUBLIC PLAYERS STOCK SUMMARY ………………. 114

10.5 COMPARATIVE ANALYSIS: KEY PLAYERS FINANICAL …………………………………………………………………… 114

10.6 KEY DEVELOPMENTS & GROWTH STRATEGIES ……………………………………………………… 115

10.6.1 PRODUCT LAUNCH/PRODUCT APPROVAL ……… 115

1 0.6.2 ACQUISITION/INVESTMENT/EXPANSION ………. 115

10.7 COMPETITOR PRODUCT ANALYSIS …………………. 116

10.7.1 OPERATING MICROSCOPES ………………………… 116

10.7.2 MICRO FORCEPS ………………………………………. 117

10.7.3 SUPER MICRO SUTURES …………………………….. 118

10.7.4 MICROSURGERY NEEDLE HOLDER ………………… 119

10.7.5 SURGICAL SCALPEL/ OPHTHALMIC KNIVES …… 120

11 COMPANY PROFILES ……………….. 121

11.1 KONTRON AG ……………………………………………………….. 121

11.1.1 COMPANY OVERVIEW ………………………………… 121

11.1.2 FINANCIAL OVERVIEW ……………………………….. 122

11.1.3 PRODUCTS OFFERED …………………………………. 123

11.1.4 KEY DEVELOPMENTS …………………………………. 124

11.1.5 KEY STRATEGIES ………………………………………. 124

11.2 CARL ZEISS MEDITEC AG …………………………………… 125

11.2.1 COMPANY OVERVIEW ………………………………… 125

11.2.2 FINANCIAL OVERVIEW ……………………………….. 126

11.2.3 PRODUCTS OFFERED …………………………………. 126

11.2.4 KEY DEVELOPMENTS …………………………………. 129

11.2.5 SWOT ANALYSIS ………………………………………. 130

11.2.6 KEY STRATEGIES ………………………………………. 130

11.3 GLOBAL SURGICAL CORPORATION …………………… 131

11.3.1 COMPANY OVERVIEW ………………………………… 131

11.3.2 FINANCIAL OVERVIEW ……………………………….. 131

11.3.3 PRODUCTS OFFERED …………………………………. 132

11.3.4 KEY DEVELOPMENTS …………………………………. 132

11.3.5 KEY STRATEGIES ………………………………………. 132

11.4 KARL KAPS GMBH & CO. KG ………………………………. 133

11.4.1 COMPANY OVERVIEW ………………………………… 133

11.4.2 FINANCIAL OVERVIEW ……………………………….. 133

11.4.3 PRODUCTS OFFERED …………………………………. 134

11.4.4 KEY DEVELOPMENTS …………………………………. 134

11.4.5 KEY STRATEGIES ………………………………………. 134

11.5 MEDTRONIC …………………………………………………………. 135

11.5.1 COMPANY OVERVIEW ………………………………… 135

11.5.2 FINANCIAL OVERVIEW ……………………………….. 136

11.5.3 PRODUCTS OFFERED …………………………………. 137

11.5.4 KEY DEVELOPMENTS …………………………………. 137

11.5.5 SWOT ANALYSIS ………………………………………. 138

11.5.6 KEY STRATEGIES ………………………………………. 138

11.6 OLYMPUS CORPORATION ………………………………….. 139

11.6.1 COMPANY OVERVIEW ………………………………… 139

11.6.2 FINANCIAL OVERVIEW ……………………………….. 140

11.6.3 PRODUCTS OFFERED …………………………………. 140

11.6.4 KEY DEVELOPMENTS …………………………………. 141

11.6.5 KEY STRATEGIES ………………………………………. 141

11.7 SMITH+NEPHEW …………………………………………………. 142

11.7.1 COMPANY OVERVIEW ………………………………… 142

11.7.2 FINANCIAL OVERVIEW ……………………………….. 143

11.7.3 PRODUCTS OFFERED …………………………………. 144

11.7.4 KEY DEVELOPMENTS …………………………………. 144

11.7.5 KEY STRATEGIES ………………………………………. 144

11.8 ZIMMER BIOMET …………………………………………………. 145

11.8.1 COMPANY OVERVIEW ………………………………… 145

11.8.2 FINANCIAL OVERVIEW ……………………………….. 146

11.8.3 PRODUCTS OFFERED …………………………………. 146

11.8.4 KEY DEVELOPMENTS …………………………………. 149

11.8.5 SWOT ANALYSIS ………………………………………. 149

11.8.6 KEY STRATEGIES ………………………………………. 149

11.9 TOPCON CORPORATION ……………………………………… 150

11.9.1 COMPANY OVERVIEW ………………………………… 150

11.9.2 FINANCIAL OVERVIEW ……………………………….. 151

11.9.3 PRODUCTS OFFERED …………………………………. 152

11.9.4 KEY DEVELOPMENTS …………………………………. 152

11.9.5 KEY STRATEGIES ………………………………………. 153

11.10 STILLE AB …………………………………………………………….. 154

11.10.1 COMPANY OVERVIEW ………………………………… 154

11.10.2 FINANCIAL OVERVIEW ……………………………….. 155

11.10.3 PRODUCTS OFFERED …………………………………. 155

11.10.4 KEY DEVELOPMENTS …………………………………. 156

1 1.10.5 KEY STRATEGIES ………………………………………. 156

11.11 B. BRAUN SE …………………………………………………………. 157

11.11.1 COMPANY OVERVIEW ………………………………… 157

11.11.2 FINANCIAL OVERVIEW ……………………………….. 158

11.11.3 PRODUCT OFFERED …………………………………… 159

11.11.4 KEY DEVELOPMENTS …………………………………. 159

11.11.5 SWOT ANALYSIS ………………………………………. 160

11.11.6 KEY STRATEGY …………………………………………….. 160

11.12 STRYKER ………………………………………………………………. 161

11.12.1 COMPANY OVERVIEW ………………………………… 161

11.12.2 FINANCIAL OVERVIEW ……………………………….. 162

11.12.3 PRODUCTS OFFERED …………………………………….. 163

11.12.4 KEY DEVELOPMENTS …………………………………. 163

11.12.5 KEY STRATEGIES ………………………………………. 163

11.13 BVI …………………………………………………………………………. 164

11.13.1 COMPANY OVERVIEW ………………………………… 164

11.13.2 FINANCIAL OVERVIEW ……………………………….. 164

11.13.3 PRODUCTS OFFERED …………………………………….. 165

11.13.4 KEY DEVELOPMENTS …………………………………. 165

11.13.5 KEY STRATEGY …………………………………………. 165

11.14 JOHNSON & JOHNSON SERVICES INC ……………… 166

11.14.1 COMPANY OVERVIEW ………………………………… 166

11.14.2 FINANCIAL OVERVIEW ……………………………….. 167

11.14.3 PRODUCTS OFFERED …………………………………. 167

11.14.4 KEY DEVELOPMENTS …………………………………. 168

11.14.5 SWOT ANALYSIS ………………………………………. 168

11.14.6 KEY STRATEGIES ………………………………………. 168

11.15 HAAG-STREIT GROUP …………………………………………. 169

11.15.1 COMPANY OVERVIEW ………………………………… 169

11.15.2 FINANCIAL OVERVIEW ……………………………….. 170

11.15.3 PRODUCTSOFFERED ………………………………….. 170

11.15.4 KEY DEVELOPMENTS …………………………………. 170

11.15.5 KEY STRATEGIES ………………………………………. 170

11.16 KLS MARTIN GROUP …………………………………………… 171

11.16.1 COMPANY OVERVIEW ………………………………… 171

11.16.2 FINANCIAL OVERVIEW ……………………………….. 172

11.16.3 PRODUCT OFFERED …………………………………… 172

11.16.4 KEY DEVELOPMENTS …………………………………. 172

11.16.5 KEY STRATEGIES ………………………………………. 172

11.17 MICROSURGERY INSTRUMENTS, INC ……………… 173

11.17.1 COMPANY OVERVIEW ………………………………… 173

11.17.2 FINANCIAL OVERVIEW ……………………………….. 173

11.17.3 PRODUCTS OFFERED………………………………….. 173

11.17.4 KEY DEVELOPMENTS …………………………………. 174

11.17.5 KEY STRATEGIES ………………………………………. 174

11.18 PETER LAZIC GMBH ……………………………………………. 175

11.18.1 COMPANY OVERVIEW ………………………………… 175

11.18.2 FINANCIAL OVERVIEW ……………………………….. 176

11.18.3 PRODUCT OFFERED …………………………………… 176

11.18.4 KEY DEVELOPMENTS …………………………………. 176

11.18.5 KEY STRATEGIES ………………………………………. 176

11.19 ALCON INC ……………………………………………………………. 177

11.19.1 COMPANY OVERVIEW ………………………………… 177

11.19.2 FINANCIAL OVERVIEW ……………………………….. 178

11.19.3 PRODUCT OFFERED …………………………………… 178

11.19.4 KEY DEVELOPMENTS …………………………………. 179

11.19.5 KEY STRATEGIES ………………………………………. 179

11.20 SYNOVIS MICRO COMPANIES ALLIANCE, INC .. 180

11.20.1 COMPANY OVERVIEW ………………………………… 180

11.20.2 FINANCIAL OVERVIEW ……………………………….. 181

11.20.3 PRODUCT OFFERED …………………………………… 181

11.20.4 KEY DEVELOPMENTS …………………………………. 181

11.20.5 KEY STRATEGIES ………………………………………. 181

12 DATA CITATIONS ……………………… 182

LIST OF TABLES

TABLE 1 QFD END USERLING FOR MARKET SHARE ASSESSMENT 37

TABLE 2 GLOBAL MICROSURGERY & SUPER-MICROSURGERY MARKET, BY EQUIPMENT, 2019–2032 (USD MILLION) 53

TABLE 3 GLOBAL MICROSURGERY & SUPER-MICROSURGERY MARKET, FOR TOPERATING MICROSCOPES, BY REGION,

2019–2032 (USD MILLION) 55

TABLE 4 GLOBAL MICROSURGERY & SUPER-MICROSURGERY MARKET, FOR SUPER MICRO SUTURES, BY REGION,

2019–2032 (USD MILLION) 55

TABLE 5 GLOBAL MICROSURGERY & SUPER-MICROSURGERY MARKET, FOR MICRO FORCEPS, BY REGION, 2019–2032 (USD MILLION) 56

TABLE 6 GLOBAL MICROSURGERY & SUPER-MICROSURGERY MARKET, FOR MICROSURGERY NEEDLE HOLDER, BY REGION,

2019–2032 (USD MILLION) 56

TABLE 7 GLOBAL MICROSURGERY & SUPER-MICROSURGERY MARKET, FOR SURGICAL SCALPEL/ OPHTHALMIC KNIVES,

BY REGION, 2019–2032 (USD MILLION) 57

TABLE 8 GLOBAL MICROSURGERY & SUPER-MICROSURGERY MARKET, FOR OTHERS, BY REGION, 2019–2032 (USD MILLION) 57

TABLE 9 GLOBAL MICROSURGERY & SUPER-MICROSURGERY MARKET, BY PROCEDURE, 2019–2032 (USD MILLION) 60

TABLE 10 GLOBAL MICROSURGERY & SUPER-MICROSURGERY MARKET, FOR ORTHOPEDIC MICROSURGERY, BY REGION, 2019–2032

(USD MILLION) 61

TABLE 11 GLOBAL MICROSURGERY & SUPER-MICROSURGERY MARKET, FOR OPHTHALMIC MICROSURGERY, BY REGION, 2019–2032

(USD MILLION) 62

TABLE 12 GLOBAL MICROSURGERY & SUPER-MICROSURGERY MARKET, FOR PLASTIC & RECONSTRUCTIVE MICROSURGERY,

BY REGION, 2019–2032 (USD MILLION) 62

TABLE 13 GLOBAL MICROSURGERY & SUPER-MICROSURGERY MARKET, FOR ENT MICROSURGERY, BY REGION, 2019–2032

(USD MILLION) 63

TABLE 14 GLOBAL MICROSURGERY & SUPER-MICROSURGERY MARKET, FOR NEUROLOGICAL MICROSURGERY, BY REGION,

2019–2032 (USD MILLION) 63

TABLE 15 GLOBAL MICROSURGERY & SUPER-MICROSURGERY MARKET, FOR GYNECOLOGICAL & UROLOGICAL MICROSURGERY,

BY REGION, 2019–2032 (USD MILLION) 64

TABLE 16 GLOBAL MICROSURGERY & SUPER-MICROSURGERY MARKET, FOR OTHERS, BY REGION, 2019–2032 (USD MILLION) 64

TABLE 17 GLOBAL MICROSURGERY & SUPER-MICROSURGERY MARKET, BY END USER, 2019–2032 (USD MILLION) 66

TABLE 18 GLOBAL MICROSURGERY & SUPER-MICROSURGERY MARKET, FOR HOSPITALS, BY REGION, 2019–2032 (USD MILLION) 67

TABLE 19 GLOBAL MICROSURGERY & SUPER-MICROSURGERY MARKET, FOR AMBULATORY SURGICAL CENTERS, BY REGION,

2019–2032 (USD MILLION) 68

TABLE 20 GLOBAL MICROSURGERY & SUPER-MICROSURGERY MARKET, FOR OTHERS, BY REGION, 2019–2032 (USD MILLION) 68

TABLE 21 GLOBAL: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY REGION, 2019–2032 (USD MILLION) 70

TABLE 22 NORTH AMERICA: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY COUNTRY, 2019–2032 (USD MILLION) 72

TABLE 23 NORTH AMERICA: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY EQUIPMENT, 2019–2032 (USD MILLION) 73

TABLE 24 NORTH AMERICA: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY PROCEDURE, 2019–2032 (USD MILLION) 74

TABLE 25 NORTH AMERICA: MICROSURGERY & SUPER-MICROSURGERY MARKET BY END USER, 2019–2032 (USD MILLION) 74

TABLE 26 US: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY EQUIPMENT, 2019–2032 (USD MILLION) 75

TABLE 27 US: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY PROCEDURE, 2019–2032 (USD MILLION) 75

TABLE 28 US: MICROSURGERY & SUPER-MICROSURGERY MARKET BY END USER, 2019–2032 (USD MILLION) 76

TABLE 29 CANADA: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY EQUIPMENT, 2019–2032 (USD MILLION) 76

TABLE 30 CANADA: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY PROCEDURE, 2019–2032 (USD MILLION) 77

TABLE 31 CANADA: MICROSURGERY & SUPER-MICROSURGERY MARKET BY END USER, 2019–2032 (USD MILLION) 77

TABLE 32 EUROPE: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY COUNTRY, 2019–2032 (USD MILLION) 79

TABLE 33 EUROPE: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY EQUIPMENT, 2019–2032 (USD MILLION) 80

TABLE 34 EUROPE: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY PROCEDURE, 2019–2032 (USD MILLION) 81

TABLE 35 EUROPE: MICROSURGERY & SUPER-MICROSURGERY MARKET BY END USER, 2019–2032 (USD MILLION) 81

TABLE 36 GERMANY: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY EQUIPMENT, 2019–2032 (USD MILLION) 82

TABLE 37 GERMANY: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY PROCEDURE, 2019–2032 (USD MILLION) 82

TABLE 38 GERMANY: MICROSURGERY & SUPER-MICROSURGERY MARKET BY END USER, 2019–2032 (USD MILLION) 83

TABLE 39 FRANCE: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY EQUIPMENT, 2019–2032 (USD MILLION) 83

TABLE 40 FRANCE: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY PROCEDURE, 2019–2032 (USD MILLION) 84

TABLE 41 FRANCE: MICROSURGERY & SUPER-MICROSURGERY MARKET BY END USER, 2019–2032 (USD MILLION) 84

TABLE 42 UK: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY EQUIPMENT, 2019–2032 (USD MILLION) 85

TABLE 43 UK: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY PROCEDURE, 2019–2032 (USD MILLION) 85

TABLE 44 UK: MICROSURGERY & SUPER-MICROSURGERY MARKET BY END USER, 2019–2032 (USD MILLION) 86

TABLE 45 ITALY: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY EQUIPMENT, 2019–2032 (USD MILLION) 86

TABLE 46 ITALY: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY PROCEDURE, 2019–2032 (USD MILLION) 87

TABLE 47 ITALY: MICROSURGERY & SUPER-MICROSURGERY MARKET BY END USER, 2019–2032 (USD MILLION) 87

TABLE 48 SPAIN: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY EQUIPMENT, 2019–2032 (USD MILLION) 88

TABLE 49 SPAIN: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY PROCEDURE, 2019–2032 (USD MILLION) 88

TABLE 50 SPAIN: MICROSURGERY & SUPER-MICROSURGERY MARKET BY END USER, 2019–2032 (USD MILLION) 89

TABLE 51 REST OF EUROPE: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY EQUIPMENT, 2019–2032 (USD MILLION) 89

TABLE 52 REST OF EUROPE: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY PROCEDURE, 2019–2032 (USD MILLION) 90

TABLE 53 REST OF EUROPE: MICROSURGERY & SUPER-MICROSURGERY MARKET BY END USER, 2019–2032 (USD MILLION) 90

TABLE 54 ASIA-PACIFIC: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY COUNTRY, 2018–2030 (USD MILLION) 93

TABLE 55 ASIA-PACIFIC: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY EQUIPMENT, 2018–2030 (USD MILLION) 93

TABLE 56 ASIA-PACIFIC: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY PROCEDURE, 2018–2030 (USD MILLION) 94

TABLE 57 ASIA-PACIFIC: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY END USER, 2018–2030 (USD MILLION) 94

TABLE 58 CHINA: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY EQUIPMENT, 2018–2030 (USD MILLION) 95

TABLE 59 CHINA: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY PROCEDURE, 2018–2030 (USD MILLION) 95

TABLE 60 CHINA: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY END USER, 2018–2030 (USD MILLION) 96

TABLE 61 JAPAN: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY EQUIPMENT, 2018–2030 (USD MILLION) 96

TABLE 62 JAPAN: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY PROCEDURE, 2018–2030 (USD MILLION) 97

TABLE 63 JAPAN: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY END USER, 2018–2030 (USD MILLION) 97

TABLE 64 INDIA: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY EQUIPMENT, 2018–2030 (USD MILLION) 98

TABLE 65 INDIA: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY PROCEDURE, 2018–2030 (USD MILLION) 98

TABLE 66 INDIA: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY END USER, 2018–2030 (USD MILLION) 99

TABLE 67 AUSTRALIA: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY EQUIPMENT, 2018–2030 (USD MILLION) 99

TABLE 68 AUSTRALIA: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY PROCEDURE, 2018–2030 (USD MILLION) 100

TABLE 69 AUSTRALIA: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY END USER, 2018–2030 (USD MILLION) 100

TABLE 70 SOUTH KOREA: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY EQUIPMENT, 2018–2030 (USD MILLION) 101

TABLE 71 SOUTH KOREA: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY PROCEDURE, 2018–2030 (USD MILLION) 101

TABLE 72 SOUTH KOREA: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY END USER, 2018–2030 (USD MILLION) 102

TABLE 73 REST OF ASIA-PACIFIC: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY EQUIPMENT, 2018–2030 (USD MILLION) 102

TABLE 74 REST OF ASIA-PACIFIC: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY PROCEDURE, 2018–2030 (USD MILLION) 103

TABLE 75 REST OF ASIA-PACIFIC: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY END USER, 2018–2030 (USD MILLION) 103

TABLE 76 REST OF THE WORLD: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY COUNTRY, 2018–2030 (USD MILLION) 106

TABLE 77 REST OF THE WORLD: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY EQUIPMENT, 2018–2030 (USD MILLION) 106

TABLE 78 REST OF THE WORLD: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY PROCEDURE, 2018–2030 (USD MILLION) 107

TABLE 79 REST OF THE WORLD: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY END USER, 2018–2030 (USD MILLION) 107

TABLE 80 MIDDLE EAST: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY EQUIPMENT, 2018–2030 (USD MILLION) 108

TABLE 81 MIDDLE EAST: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY PROCEDURE, 2018–2030 (USD MILLION) 108

TABLE 82 MIDDLE EAST: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY END USER, 2018–2030 (USD MILLION) 109

TABLE 83 SOUTH AMERICA: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY EQUIPMENT, 2018–2030 (USD MILLION) 109

TABLE 84 SOUTH AMERICA: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY PROCEDURE, 2018–2030 (USD MILLION) 110

TABLE 85 SOUTH AMERICA: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY END USER, 2018–2030 (USD MILLION) 110

TABLE 86 PUBLIC PLAYERS STOCK SUMMARY 114

TABLE 87 COMPARATIVE ANALYSIS: KEY PLAYERS FINANICAL 114

TABLE 88 PRODUCT LAUNCH/PRODUCT APPROVAL 115

TABLE 89 ACQUISITION /INVESTMENT/EXPANSION/COLLABORATION 115

TABLE 90 KONTRON AG: PRODUCTS OFFERED 123

TABLE 91 CARL ZEISS MEDITEC AG: PRODUCTS OFFERED 126

TABLE 92 CARL ZEISS MEDITEC AG: KEY DEVELOPMENTS 129

TABLE 93 GLOBAL SURGICAL CORPORATION: PRODCUTS OFFERED 132

TABLE 94 KARL KAPS GMBH & CO. KG: PRODCUTS OFFERED 134

TABLE 95 MEDTRONIC: PRODCUTS OFFERED 137

TABLE 96 OLYMPUS CORPORATION: PRODCUTS OFFERED 140

TABLE 97 SMITH+NEPHEW: PRODCUTS OFFERED 144

TABLE 98 ZIMMER BIOMET: PRODCUTS OFFERED 146

TABLE 99 TOPCON CORPORATION: PRODCUTS OFFERED 152

TABLE 100 STILLE AB: PRODCUTS OFFERED 155

TABLE 101 STILLE AB: KEY DEVELOPMENTS 156

TABLE 102 B. BRAUN SE: PRODUCTS OFFERED 159

TABLE 103 STRYKER: PRODCUTS OFFERED 163

TABLE 104 BVI: PRODCUTS OFFERED 165

TABLE 105 BVI: KEY DEVELOPMENTS 165

TABLE 106 JOHNSON & JOHNSON SERVICES INC: PRODUCTS OFFERED 167

TABLE 107 HAAG-STREIT GROUP: PRODUCTS OFFERED 170

TABLE 108 KLS MARTIN GROUP: PRODUCTSOFFERED 172

TABLE 109 MICROSURGERY INSTRUMENTS, INC: PRODUCTS OFFERED 173

TABLE 110 PETER LAZIC GMBH: PRODUCT OFFERED 176

TABLE 111 ALCON: PRODUCT OFFERED 178

TABLE 112 SYNOVIS MICRO COMPANIES ALLIANCE, INC: PRODUCT OFFERED 181

TABLE 113 SYNOVIS MICRO COMPANIES ALLIANCE, INC: KEY DEVELOPMENTS 181

LIST OF FIGURES

FIGURE 1 GLOBAL MICROSURGERY & SUPER-MICROSURGERY MARKET: STRUCTURE 24

FIGURE 2 GLOBAL MICROSURGERY AND SUPER-MICROSURGERY MARKET: MARKET GROWTH FACTOR ANALYSIS (2022-2032) 40

FIGURE 3 DRIVER IMPACT ANALYSIS (2023-2032) 42

FIGURE 4 RESTRAINT IMPACT ANALYSIS (2022-2032) 43

FIGURE 5 VALUE CHAIN ANALYSIS OF THE GLOBAL MICROSURGERY & SUPER-MICROSURGERY MARKET 45

FIGURE 6 PORTER’S FIVE FORCES ANALYSIS: GLOBAL MICROSURGERY & SUPER-MICROSURGERY MARKET 48

FIGURE 7 GLOBAL MICROSURGERY & SUPER-MICROSURGERY MARKET, EQUIPMENT SEGMENT ATTRACTIVENESS, 2019–2032

(USD MILLION) 53

FIGURE 8 GLOBAL MICROSURGERY & SUPER-MICROSURGERY MARKET, BY EQUIPMENT, 2022 & 2032(USD MILLION) 53

FIGURE 9 GLOBAL MICROSURGERY & SUPER-MICROSURGERY MARKET SHARE, BY EQUIPMENT, 2022 (%) 54

FIGURE 10 GLOBAL MICROSURGERY & SUPER-MICROSURGERY MARKET, PROCEDURE SEGMENT ATTRACTIVENESS, 2019–2032

(USD MILLION) 59

FIGURE 11 GLOBAL MICROSURGERY & SUPER-MICROSURGERY MARKET, BY PROCEDURE, 2022 & 2032(USD MILLION) 60

FIGURE 12 GLOBAL MICROSURGERY & SUPER-MICROSURGERY MARKET SHARE, BY PROCEDURE, 2022 (%) 61

FIGURE 13 GLOBAL MICROSURGERY & SUPER-MICROSURGERY MARKET, END USER SEGMENT ATTRACTIVENESS, 2019–2032

(USD MILLION) 65

FIGURE 14 GLOBAL MICROSURGERY & SUPER-MICROSURGERY MARKET, BY END USER, 2022 & 2032(USD MILLION) 66

FIGURE 15 GLOBAL MICROSURGERY & SUPER-MICROSURGERY MARKET SHARE, BY END USER, 2022 (%) 67

FIGURE 16 GLOBAL: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY REGION, 2022 & 2032 (USD MILLION) 69

FIGURE 17 GLOBAL: MICROSURGERY & SUPER-MICROSURGERY MARKET SHARE (%), BY REGION, 2022 70

FIGURE 18 NORTH AMERICA MARKET ANALYSIS: MICROSURGERY & SUPER-MICROSURGERY MARKET, 2019-2032 (USD MILLION) 71

FIGURE 19 NORTH AMERICA: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY COUNTRY, 2022 & 2032 (USD MILLION) 72

FIGURE 20 NORTH AMERICA: MICROSURGERY & SUPER-MICROSURGERY MARKET SHARE (%), BY COUNTRY, 2022 73

FIGURE 21 EUROPE MARKET ANALYSIS: MICROSURGERY & SUPER-MICROSURGERY MARKET, 2019-2032 (USD MILLION) 78

FIGURE 22 EUROPE: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY COUNTRY, 2022 & 2032 (USD MILLION) 79

FIGURE 23 EUROPE: MICROSURGERY & SUPER-MICROSURGERY MARKET SHARE (%), BY COUNTRY, 2022 80

FIGURE 24 ASIA-PACIFIC: MICROSURGERY & SUPER-MICROSURGERY MARKET, 2019-2032 (USD MILLION) 91

FIGURE 25 ASIA-PACIFIC: MICROSURGERY & SUPER-MICROSURGERY MARKET SHARE, BY COUNTRY, 2022 (% SHARE) 92

FIGURE 26 ASIA-PACIFIC: MICROSURGERY & SUPER-MICROSURGERY MARKET SHARE, BY COUNTRY, 2022 & 2032 (USD MILLION) 92

FIGURE 27 REST OF THE WORLD: MICROSURGERY & SUPER-MICROSURGERY MARKET, 2019-2032 (USD MILLION) 104

FIGURE 28 REST OF WORLD: MICROSURGERY & SUPER-MICROSURGERY MARKET SHARE, BY COUNTRY, 2022 (% SHARE) 105

FIGURE 29 REST OF WORLD: MICROSURGERY & SUPER-MICROSURGERY MARKET SHARE, BY COUNTRY, 2021 & 2030 (USD MILLION) 105

FIGURE 30 GLOBAL MICROSURGERY & SUPER-MICROSURGERY PLAYERS: COMPETITIVE ANALSIS, 2022 111

FIGURE 31 COMPETITOR DASHBOARD: GLOBAL MICROSURGERY & SUPER-MICROSURGERY MARKET 112

FIGURE 32 COMPETITORS PRODUCT ANALYSIS: OPERATING MICROSCOPES 116

FIGURE 33 COMPETITORS PRODUCT ANALYSIS: MICRO FORCEPS 117

FIGURE 34 COMPETITORS PRODUCT ANALYSIS: SUPER MICRO SUTURES 118

FIGURE 35 COMPETITORS PRODUCT ANALYSIS: MICROSURGERY NEEDLE HOLDER 119

FIGURE 36 COMPETITORS PRODUCT ANALYSIS: SURGICAL SCALPEL/ OPHTHALMIC KNIVES 120

FIGURE 37 KONTRON AG: FINANCIAL OVERVIEW SNAPSHOT 122

FIGURE 38 CARL ZEISS MEDITEC AG: FINANCIAL OVERVIEW SNAPSHOT 126

FIGURE 39 CARL ZEISS MEDITEC AG: SWOT ANALYSIS 130

FIGURE 40 MEDTRONIC: FINANCIAL OVERVIEW SNAPSHOT 136

FIGURE 41 MEDTRONIC: SWOT ANALYSIS 138

FIGURE 42 OLYMPUS CORPORATION: FINANCIAL OVERVIEW SNAPSHOT 140

FIGURE 43 SMITH+NEPHEW: FINANCIAL OVERVIEW SNAPSHOT 143

FIGURE 44 ZIMMER BIOMET: FINANCIAL OVERVIEW SNAPSHOT 146

FIGURE 45 ZIMMER BIOMET: SWOT ANALYSIS 149

FIGURE 46 TOPCON CORPORATION: FINANCIAL OVERVIEW SNAPSHOT 151

FIGURE 47 STILLE AB: FINANCIAL OVERVIEW SNAPSHOT 155

FIGURE 48 B. BRAUN SE: FINANCIAL OVERVIEW SNAPSHOT 158

FIGURE 49 B. BRAUN SE: SWOT ANALYSIS 160

FIGURE 50 STRYKER: FINANCIAL OVERVIEW SNAPSHOT 162

FIGURE 51 JOHNSON & JOHNSON SERVICES INC.: FINANCIAL OVERVIEW SNAPSHOT 167

FIGURE 52 JOHNSON & JOHNSON SERVICES INC: SWOT ANALYSIS 168

FIGURE 53 ALCON INC: FINANCIAL OVERVIEW SNAPSHOT 178

医療・医薬の最新記事8件